|
1
|
Siegel R, Ward E, Brawley O and Jemal A:
Cancer statistics, 2011: The impact of eliminating socioeconomic
and racial disparities on premature cancer deaths. CA Cancer J
Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zükin M: Epidermal growth factor receptor
inhibitors in non-small cell lung cancer: Current status and future
perspectives. Rev Assoc Med Bras. 58:263–268. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kuo PL, Liao SH, Hung JY, Huang MS and Hsu
YL: Micro-RNA-33a functions as a bone metastasis suppressor in lung
cancer by targeting parathyroid hormone related protein. Biochim
Biophys Acta. 1830:3756–3766. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Al Husaini H, Wheatley-Price P, Clemons M
and Shepherd FA: Prevention and management of bone metastases in
lung cancer: A review. J Thorac Oncol. 4:251–259. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hirsh V, Major PP, Lipton A, Cook RJ,
Langer CJ, Smith MR, Brown JE and Coleman RE: Zoledronic acid and
survival in patients with metastatic bone disease from lung cancer
and elevated markers of osteoclast activity. J Thorac Oncol.
3:228–236. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sterling JA, Edwards JR, Martin TJ and
Mundy GR: Advances in the biology of bone metastasis: How the
skeleton affects tumor behavior. Bone. 48:6–15. 2011. View Article : Google Scholar
|
|
7
|
Sims NA and Gooi JH: Bone remodeling:
Multiple cellular interactions required for coupling of bone
formation and resorption. Semin Cell Dev Biol. 19:444–451. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Miller RE, Jones JC, Tometsko M, Blake ML
and Dougall WC: RANKL inhibition blocks osteolytic lesions and
reduces skeletal tumor burden in models of non-small-cell lung
cancer bone metastases. J Thorac Oncol. 9:345–354. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Esposito M and Kang Y: Targeting
tumor-stromal interactions in bone metastasis. Pharmacol Ther.
141:222–233. 2014. View Article : Google Scholar :
|
|
10
|
Phillips DH: Polycyclic aromatic
hydrocarbons in the diet. Mutat Res. 443:139–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Anastasio A, Mercogliano R, Vollano L,
Pepe T and Cortesi ML: Levels of benzo[a]pyrene (BaP) in
‘mozzarella di bufala campana’ cheese smoked according to different
procedures. J Agric Food Chem. 52:4452–4455. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Domingo JL: Influence of cooking processes
on the concentrations of toxic metals and various organic
environmental pollutants in food: A review of the published
literature. Crit Rev Food Sci Nutr. 51:29–37. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guillén MD, Sopelana P and Partearroyo MA:
Food as a source of polycyclic aromatic carcinogens. Rev Environ
Health. 12:133–146. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rota M, Bosetti C, Boccia S, Boffetta P
and La Vecchia C: Occupational exposures to polycyclic aromatic
hydrocarbons and respiratory and urinary tract cancers: An updated
systematic review and a meta-analysis to 2014. Arch Toxicol.
88:1479–1490. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Burstyn I, Boffetta P, Heederik D, et al:
Mortality from obstructive lung diseases and exposure to polycyclic
aromatic hydrocarbons among asphalt workers. Am J Epidemiol.
158:468–478. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Boffetta P, Burstyn I, Partanen T, et al:
Cancer mortality among European asphalt workers: An international
epidemiological study. I. Results of the analysis based on job
titles. Am J Ind Med. 43:18–27. 2003. View Article : Google Scholar
|
|
17
|
Iizasa T, Momiki S, Bauer B, Caamano J,
Metcalf R, Lechner J, Harris CC and Klein-Szanto AJ: Invasive
tumors derived from xenotransplanted, immortalized human cells
after in vivo exposure to chemical carcinogens. Carcinogenesis.
14:1789–1794. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Melchiori A, Colacci A, Lollini PL, De
Giovanni C, Carlone S, Grilli S, Parodi S and Albini A: Induction
of invasive and experimental metastasis potential in BALB/c 3T3
cells by benzo(a)pyrene transformation. Invasion Metastasis.
12:1–11. 1992.PubMed/NCBI
|
|
19
|
Ueng TH, Chang YL, Tsai YY, Su JL, Chan
PK, Shih JY, Lee YC, Ma YC and Kuo ML: Potential roles of
fibroblast growth factor-9 in the benzo(a)pyrene-induced invasion
in vitro and the metastasis of human lung adenocarcinoma. Arch
Toxicol. 84:651–660. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yoshino I, Kometani T, Shoji F, Osoegawa
A, Ohba T, Kouso H, Takenaka T, Yohena T and Maehara Y: Induction
of epithelial-mesenchymal transition-related genes by
benzo[a]-pyrene in lung cancer cells. Cancer. 110:369–374. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang Y, Zhai W, Wang H, Xia X and Zhang C:
Benzo(a)pyrene promotes A549 cell migration and invasion through
up-regulating Twist. Arch Toxicol. May 22–2014.(Epub ahead of
print).
|
|
22
|
Martos I, Ferreres F and Tomás-Barberán
FA: Identification of flavonoid markers for the botanical origin of
Eucalyptus honey. J Agric Food Chem. 48:1498–1502. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Martos I, Ferreres F, Yao L, D’Arcy B,
Caffin N and Tomás-Barberán FA: Flavonoids in monospecific
eucalyptus honeys from Australia. J Agric Food Chem. 48:4744–4748.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yao L, Jiang Y, D’Arcy B, Singanusong R,
Datta N, Caffin N and Raymont K: Quantitative high-performance
liquid chromatography analyses of flavonoids in Australian
Eucalyptus honeys. J Agric Food Chem. 52:210–214. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Geraets L, Moonen HJ, Brauers K, Wouters
EF, Bast A and Hageman GJ: Dietary flavones and flavonoles are
inhibitors of poly(ADP-ribose)polymerase-1 in pulmonary epithelial
cells. J Nutr. 137:2190–2195. 2007.PubMed/NCBI
|
|
26
|
Hsu YL, Uen YH, Chen Y, Liang HL and Kuo
PL: Tricetin, a dietary flavonoid, inhibits proliferation of human
breast adenocarcinoma mcf-7 cells by blocking cell cycle
progression and inducing apoptosis. J Agric Food Chem.
57:8688–8695. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hsu YL, Hou MF, Tsai EM and Kuo PL:
Tricetin, a dietary flavonoid, induces apoptosis through the
reactive oxygen species/c-Jun NH2-terminal kinase pathway in human
liver cancer cells. J Agric Food Chem. 58:12547–12556. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Casimiro S, Mohammad KS, Pires R, et al:
RANKL/RANK/MMP-1 molecular triad contributes to the metastatic
phenotype of breast and prostate cancer cells in vitro. PLoS One.
8:e631532013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Krishnan V, Vogler EA, Sosnoski DM and
Mastro AM: In vitro mimics of bone remodeling and the vicious cycle
of cancer in bone. J Cell Physiol. 229:453–462. 2014. View Article : Google Scholar
|
|
30
|
Manenti G, Peissel B, Gariboldi M, et al:
A cancer modifier role for parathyroid hormone-related protein.
Oncogene. 19:5324–5328. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wu X, Liu T, Fang O, Leach LJ, Hu X and
Luo Z: miR-194 suppresses metastasis of non-small cell lung cancer
through regulating expression of BMP1 and p27(kip1). Oncogene.
33:1506–1514. 2014. View Article : Google Scholar
|
|
32
|
Hernández I, Moreno JL, Zandueta C,
Montuenga L and Lecanda F: Novel alternatively spliced ADAM8
isoforms contribute to the aggressive bone metastatic phenotype of
lung cancer. Oncogene. 29:3758–3769. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sone S and Yano S: Molecular pathogenesis
and its therapeutic modalities of lung cancer metastasis to bone.
Cancer Metastasis Rev. 26:685–689. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Weilbaecher KN, Guise TA and McCauley LK:
Cancer to bone: A fatal attraction. Nat Rev Cancer. 11:411–425.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Coleman RE and McCloskey EV:
Bisphosphonates in oncology. Bone. 49:71–76. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hiraki A, Ueoka H, Bessho A, Segawa Y,
Takigawa N, Kiura K, Eguchi K, Yoneda T, Tanimoto M and Harada M:
Parathyroid hormone-related protein measured at the time of first
visit is an indicator of bone metastases and survival in lung
carcinoma patients with hypercalcemia. Cancer. 95:1706–1713. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hsu YL, Tsai EM, Hou MF, Wang TN, Hung JY
and Kuo PL: Obtusifolin suppresses phthalate esters-induced breast
cancer bone metastasis by targeting parathyroid hormone-related
protein. J Agric Food Chem. 62:11933–11940. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shen X and Falzon M: PTH-related protein
upregulates integrin alpha6beta4 expression and activates Akt in
breast cancer cells. Exp Cell Res. 312:3822–3834. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kitazawa S and Kitazawa R: RANK ligand is
a prerequisite for cancer-associated osteolytic lesions. J Pathol.
198:228–236. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Thomas RJ, Guise TA, Yin JJ, Elliott J,
Horwood NJ, Martin TJ and Gillespie MT: Breast cancer cells
interact with osteoblasts to support osteoclast formation.
Endocrinology. 140:4451–4458. 1999.PubMed/NCBI
|
|
41
|
Yasuda H, Shima N, Nakagawa N, et al: A
novel molecular mechanism modulating osteoclast differentiation and
function. Bone. 25:109–113. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Jansen ID, Vermeer JA, Bloemen V, Stap J
and Everts V: Osteoclast fusion and fission. Calcif Tissue Int.
90:515–522. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lacey DL, Timms E, Tan HL, et al:
Osteoprotegerin ligand is a cytokine that regulates osteoclast
differentiation and activation. Cell. 93:165–176. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Jun AY, Kim HJ, Park KK, Son KH, Lee DH,
Woo MH and Chung WY: Tetrahydrofurofuran-type lignans inhibit
breast cancer-mediated bone destruction by blocking the vicious
cycle between cancer cells, osteoblasts and osteoclasts. Invest New
Drugs. 32:1–13. 2014. View Article : Google Scholar
|
|
45
|
Bendre MS, Margulies AG, Walser B, et al:
Tumor-derived interleukin-8 stimulates osteolysis independent of
the receptor activator of nuclear factor-kappaB ligand pathway.
Cancer Res. 65:11001–11009. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hsu YL, Hung JY, Ko YC, Hung CH, Huang MS
and Kuo PL: Phospholipase D signaling pathway is involved in lung
cancer-derived IL-8 increased osteoclastogenesis. Carcinogenesis.
31:587–596. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Lewiecki EM: Safety of long-term
bisphosphonate therapy for the management of osteoporosis. Drugs.
71:791–814. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Papapetrou PD: Bisphosphonate-associated
adverse events. Hormones (Athens). 8:96–110. 2009. View Article : Google Scholar
|
